(JILL) J.Jill - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US46620W2017
Stock: Apparel, Footwear, Accessories
Total Rating 26
Risk 65
Buy Signal -0.46
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.98% |
| Yield on Cost 5y | 7.22% |
| Yield CAGR 5y | 52.38% |
| Payout Consistency | 36.3% |
| Payout Ratio | 11.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 46.1% |
| Relative Tail Risk | -5.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.65 |
| Alpha | -50.05 |
| Character TTM | |
|---|---|
| Beta | 1.185 |
| Beta Downside | 0.959 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.49% |
| CAGR/Max DD | -0.23 |
Description: JILL J.Jill January 02, 2026
J.Jill, Inc. (NYSE:JILL) is an omnichannel retailer focused on women’s apparel, footwear, and accessories in the United States, selling under its primary brand and three sub-brands-Pure Jill, Wearever, and Fit-through brick-and-mortar stores, e-commerce, and catalog channels. Founded in 1959 and headquartered in Quincy, Massachusetts, the company operates within the Apparel Retail sub-industry.
Key performance indicators from FY 2023 show revenue of approximately $1.1 billion, with e-commerce accounting for roughly 45 % of total sales and comparable-store sales growing 3 % year-over-year. Inventory turnover improved to 4.2×, reflecting tighter supply-chain management, while the gross margin held steady near 38 %, a figure that tracks closely with broader consumer-discretionary trends such as inflation-adjusted spending and shifting consumer preferences toward casual and comfort-focused apparel.
For a deeper quantitative assessment, you might explore ValueRay’s detailed valuation models for J.Jill.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 33.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.28 > 1.0 |
| NWC/Revenue: 3.26% < 20% (prev -0.66%; Δ 3.92% < -1%) |
| CFO/TA 0.11 > 3% & CFO 51.8m > Net Income 33.7m |
| Net Debt (95.8m) to EBITDA (73.8m): 1.30 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.4m) vs 12m ago -0.85% < -2% |
| Gross Margin: 69.42% > 18% (prev 0.69%; Δ 6873 % > 0.5%) |
| Asset Turnover: 137.2% > 50% (prev 147.6%; Δ -10.46% > 0%) |
| Interest Coverage Ratio: 3.88 > 6 (EBITDA TTM 73.8m / Interest Expense TTM 10.9m) |
Altman Z'' -0.15
| A: 0.04 (Total Current Assets 150.3m - Total Current Liabilities 130.7m) / Total Assets 458.0m |
| B: -0.23 (Retained Earnings -105.2m / Total Assets 458.0m) |
| C: 0.10 (EBIT TTM 42.3m / Avg Total Assets 438.1m) |
| D: -0.32 (Book Value of Equity -105.1m / Total Liabilities 328.9m) |
| Altman-Z'' Score: -0.15 = B |
Beneish M -3.36
| DSRI: 0.76 (Receivables 4.86m/6.54m, Revenue 601.0m/617.5m) |
| GMI: 0.99 (GM 69.42% / 68.64%) |
| AQI: 0.89 (AQ_t 0.27 / AQ_t-1 0.31) |
| SGI: 0.97 (Revenue 601.0m / 617.5m) |
| TATA: -0.04 (NI 33.7m - CFO 51.8m) / TA 458.0m) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of JILL shares?
As of February 07, 2026, the stock is trading at USD 16.80 with a total of 16,585 shares traded.
Over the past week, the price has changed by +7.62%, over one month by +16.10%, over three months by +14.85% and over the past year by -33.36%.
Over the past week, the price has changed by +7.62%, over one month by +16.10%, over three months by +14.85% and over the past year by -33.36%.
Is JILL a buy, sell or hold?
J.Jill has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy JILL.
- StrongBuy: 4
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JILL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | 7.1% |
| Analysts Target Price | 18 | 7.1% |
| ValueRay Target Price | 16.3 | -2.9% |
JILL Fundamental Data Overview February 03, 2026
P/E Trailing = 7.2269
P/E Forward = 7.2098
P/S = 0.3955
P/B = 1.8471
P/EG = 0.63
Revenue TTM = 601.0m USD
EBIT TTM = 42.3m USD
EBITDA TTM = 73.8m USD
Long Term Debt = 70.3m USD (from longTermDebt, last quarter)
Short Term Debt = 38.9m USD (from shortTermDebt, last quarter)
Debt = 153.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 95.8m USD (from netDebt column, last quarter)
Enterprise Value = 333.5m USD (237.7m + Debt 153.8m - CCE 58.0m)
Interest Coverage Ratio = 3.88 (Ebit TTM 42.3m / Interest Expense TTM 10.9m)
EV/FCF = 8.05x (Enterprise Value 333.5m / FCF TTM 41.4m)
FCF Yield = 12.42% (FCF TTM 41.4m / Enterprise Value 333.5m)
FCF Margin = 6.89% (FCF TTM 41.4m / Revenue TTM 601.0m)
Net Margin = 5.60% (Net Income TTM 33.7m / Revenue TTM 601.0m)
Gross Margin = 69.42% ((Revenue TTM 601.0m - Cost of Revenue TTM 183.8m) / Revenue TTM)
Gross Margin QoQ = 70.90% (prev 68.42%)
Tobins Q-Ratio = 0.73 (Enterprise Value 333.5m / Total Assets 458.0m)
Interest Expense / Debt = 1.76% (Interest Expense 2.70m / Debt 153.8m)
Taxrate = 28.01% (3.58m / 12.8m)
NOPAT = 30.5m (EBIT 42.3m * (1 - 28.01%))
Current Ratio = 1.15 (Total Current Assets 150.3m / Total Current Liabilities 130.7m)
Debt / Equity = 1.19 (Debt 153.8m / totalStockholderEquity, last quarter 129.0m)
Debt / EBITDA = 1.30 (Net Debt 95.8m / EBITDA 73.8m)
Debt / FCF = 2.31 (Net Debt 95.8m / FCF TTM 41.4m)
Total Stockholder Equity = 117.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.68% (Net Income 33.7m / Total Assets 458.0m)
RoE = 28.75% (Net Income TTM 33.7m / Total Stockholder Equity 117.1m)
RoCE = 22.59% (EBIT 42.3m / Capital Employed (Equity 117.1m + L.T.Debt 70.3m))
RoIC = 16.31% (NOPAT 30.5m / Invested Capital 186.9m)
WACC = 6.74% (E(237.7m)/V(391.5m) * Re(10.28%) + D(153.8m)/V(391.5m) * Rd(1.76%) * (1-Tc(0.28)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.10%
[DCF Debug] Terminal Value 80.76% ; FCFF base≈43.8m ; Y1≈37.2m ; Y5≈28.4m
Fair Price DCF = 38.72 (EV 681.1m - Net Debt 95.8m = Equity 585.3m / Shares 15.1m; r=6.74% [WACC]; 5y FCF grow -18.24% → 2.90% )
EPS Correlation: -30.85 | EPS CAGR: -49.61% | SUE: -1.91 | # QB: 0
Revenue Correlation: -4.08 | Revenue CAGR: 0.97% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.93 | Chg30d=+0.017 | Revisions Net=-2 | Analysts=3
EPS next Year (2027-01-31): EPS=2.76 | Chg30d=+0.122 | Revisions Net=+5 | Growth EPS=+18.2% | Growth Revenue=+2.9%
P/E Forward = 7.2098
P/S = 0.3955
P/B = 1.8471
P/EG = 0.63
Revenue TTM = 601.0m USD
EBIT TTM = 42.3m USD
EBITDA TTM = 73.8m USD
Long Term Debt = 70.3m USD (from longTermDebt, last quarter)
Short Term Debt = 38.9m USD (from shortTermDebt, last quarter)
Debt = 153.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 95.8m USD (from netDebt column, last quarter)
Enterprise Value = 333.5m USD (237.7m + Debt 153.8m - CCE 58.0m)
Interest Coverage Ratio = 3.88 (Ebit TTM 42.3m / Interest Expense TTM 10.9m)
EV/FCF = 8.05x (Enterprise Value 333.5m / FCF TTM 41.4m)
FCF Yield = 12.42% (FCF TTM 41.4m / Enterprise Value 333.5m)
FCF Margin = 6.89% (FCF TTM 41.4m / Revenue TTM 601.0m)
Net Margin = 5.60% (Net Income TTM 33.7m / Revenue TTM 601.0m)
Gross Margin = 69.42% ((Revenue TTM 601.0m - Cost of Revenue TTM 183.8m) / Revenue TTM)
Gross Margin QoQ = 70.90% (prev 68.42%)
Tobins Q-Ratio = 0.73 (Enterprise Value 333.5m / Total Assets 458.0m)
Interest Expense / Debt = 1.76% (Interest Expense 2.70m / Debt 153.8m)
Taxrate = 28.01% (3.58m / 12.8m)
NOPAT = 30.5m (EBIT 42.3m * (1 - 28.01%))
Current Ratio = 1.15 (Total Current Assets 150.3m / Total Current Liabilities 130.7m)
Debt / Equity = 1.19 (Debt 153.8m / totalStockholderEquity, last quarter 129.0m)
Debt / EBITDA = 1.30 (Net Debt 95.8m / EBITDA 73.8m)
Debt / FCF = 2.31 (Net Debt 95.8m / FCF TTM 41.4m)
Total Stockholder Equity = 117.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.68% (Net Income 33.7m / Total Assets 458.0m)
RoE = 28.75% (Net Income TTM 33.7m / Total Stockholder Equity 117.1m)
RoCE = 22.59% (EBIT 42.3m / Capital Employed (Equity 117.1m + L.T.Debt 70.3m))
RoIC = 16.31% (NOPAT 30.5m / Invested Capital 186.9m)
WACC = 6.74% (E(237.7m)/V(391.5m) * Re(10.28%) + D(153.8m)/V(391.5m) * Rd(1.76%) * (1-Tc(0.28)))
Discount Rate = 10.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.10%
[DCF Debug] Terminal Value 80.76% ; FCFF base≈43.8m ; Y1≈37.2m ; Y5≈28.4m
Fair Price DCF = 38.72 (EV 681.1m - Net Debt 95.8m = Equity 585.3m / Shares 15.1m; r=6.74% [WACC]; 5y FCF grow -18.24% → 2.90% )
EPS Correlation: -30.85 | EPS CAGR: -49.61% | SUE: -1.91 | # QB: 0
Revenue Correlation: -4.08 | Revenue CAGR: 0.97% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.93 | Chg30d=+0.017 | Revisions Net=-2 | Analysts=3
EPS next Year (2027-01-31): EPS=2.76 | Chg30d=+0.122 | Revisions Net=+5 | Growth EPS=+18.2% | Growth Revenue=+2.9%